EXPRESSION OF ICAM-R (ICAM-3), A NOVEL COUNTER-RECEPTOR FOR LFA-1, IN RHEUMATOID AND NONRHEUMATOID SYNOVIUM - COMPARISON WITH OTHER ADHESION MOLECULES

被引:46
作者
ELGABALAWY, H
GALLATIN, M
VAZEUX, R
PETERMAN, G
WILKINS, J
机构
[1] ICOS CORP,SEATTLE,WA
[2] UNIV MANITOBA,WINNIPEG R3T 2N2,MB,CANADA
来源
ARTHRITIS AND RHEUMATISM | 1994年 / 37卷 / 06期
关键词
D O I
10.1002/art.1780370612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To study the distribution of intercellular adhesion molecule receptor (ICAM-R, or ICAM-3), a novel ligand for the leukointegrin lymphocyte function-associated antigen 1 (LFA-1), in normal and rheumatoid synovial membranes and to compare this with the distribution of ICAM-1, ICAM-2, vascular cell adhesion molecule 1 (VCAM-1), and endothelial leukocyte adhesion molecule 1 (ELAM-1). Methods. We performed immunohistochemical analyses of frozen sections of normal and rheumatoid synovial tissue using monoclonal antibodies to the molecules examined. Results. ICAM-1 staining was detectable on the vascular endothelium and the synovial lining cells of both normal and rheumatoid synovial membranes. A variable proportion of lymphocytes infiltrating rheumatoid tissues expressed ICAM-1. ICAM-2 staining was demonstrable in the vascular endothelium of both normal and inflamed tissues, the latter demonstrating a significantly higher proportion of positive vessels. ELAM-1 staining was not detectable in normal synovial membranes but was seen on the endothelium of a limited number of rheumatoid synovial vessels, usually close to the synovial lining cell layer. VCAM-1 staining was intense in both normal and rheumatoid synovial lining cells, but vascular staining was weak in both. In contrast, ICAM-R staining was not detected in association with any synovial blood vessels, but was widely expressed by lymphocytes and macrophages. Cells of the lining layer did not stain for ICAM-R. Conclusion. Although ICAM-R is a ligand for LFA-1 and shares considerable sequence homology with ICAM-1 and ICAM-2, it does not appear to be expressed by the endothelium of normal or inflamed synovial vessels. Intense expression of ICAM-R by rheumatoid synovial lymphocytes and macrophages suggests that it may play a role in processes requiring cell-cell contact, such as antigen presentation and homotypic aggregation.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 46 条
[1]   EXPRESSION OF THE ADHESION MOLECULES ICAM-1 AND ICAM-2 ON TUMOR-CELL LINES DOES NOT CORRELATE WITH THEIR SUSCEPTIBILITY TO NATURAL-KILLER CELL-MEDIATED CYTOLYSIS - EVIDENCE FOR ADDITIONAL LIGANDS FOR EFFECTOR CELL BETA-2 INTEGRINS [J].
AKELLA, R ;
HALL, RE .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (04) :1069-1074
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   FUNCTIONAL INVOLVEMENT OF THE LFA-1 ICAM-1 ADHESION SYSTEM IN THE AUTOLOGOUS MIXED LYMPHOCYTE-REACTION [J].
BAGNASCO, M ;
PESCE, G ;
PRONZATO, C ;
CANONICA, GW .
CELLULAR IMMUNOLOGY, 1990, 128 (02) :362-369
[4]  
BERG EL, 1989, IMMUNOL REV, V108, P1
[5]   IDENTIFICATION OF AN INDUCIBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE [J].
BEVILACQUA, MP ;
POBER, JS ;
MENDRICK, DL ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9238-9242
[6]   INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) HAS A CENTRAL ROLE IN CELL CELL CONTACT-MEDIATED IMMUNE-MECHANISMS [J].
BOYD, AW ;
WAWRYK, SO ;
BURNS, GF ;
FECONDO, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3095-3099
[7]   LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY [J].
BUTCHER, EC .
CELL, 1991, 67 (06) :1033-1036
[8]  
CARLOS TM, 1990, BLOOD, V76, P965
[9]  
CORKILL MM, 1991, J RHEUMATOL, V18, P1453
[10]  
COSIMI AB, 1990, J IMMUNOL, V144, P4604